Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phoxgene on vascular superoxide production in atherosclerosis

Citation
Tj. Guzik et al., Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phoxgene on vascular superoxide production in atherosclerosis, CIRCULATION, 102(15), 2000, pp. 1744-1747
Citations number
11
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
CIRCULATION
ISSN journal
00097322 → ACNP
Volume
102
Issue
15
Year of publication
2000
Pages
1744 - 1747
Database
ISI
SICI code
0009-7322(20001010)102:15<1744:FEOTCP>2.0.ZU;2-G
Abstract
Background-Increased superoxide anion production increases oxidative stress and reduces nitric oxide bioactivity in vascular disease states. NAD(P)H o xidase is an important source of superoxide in human blood vessels, and som e studies suggest a possible association between polymorphisms in the NAD(P )H oxidase CYBA gene and atherosclerosis; however, no functional data addre ss this hypothesis. We examined the relationships between the CYBA C242T po lymorphism and direct measurements of superoxide production in human blood vessels. Methods and Results-Vascular NAD(P)H oxidase activity was determined ill hu man saphenous veins obtained from 110 patients with coronary artery disease and identified risk factors. Immunoblotting, reverse-transcription polymer ase chain reaction, and DNA sequencing showed that p22phox protein, mRNA, a nd 242C/T allelic variants are expressed in human blood vessels. Vascular s uperoxide production, both basal and NADH-stimulated, was highly variable b etween patients, but the presence of the CYBA 242T allele was associated wi th significantly reduced vascular NAD(P)H oxidase activity, independent of other clinical risk factors for atherosclerosis. Conclusions-Association of the CYBA 242T allele with reduced NAD(P)H oxidas e activity in human blood vessels suggests that genetic variation in NAD(P) H oxidase components may play a significant role in modulating superoxide p roduction in human atherosclerosis.